Table 1.
Characteristics of participants at baseline assessments.
| Characteristics | Treatment group (n = 26) | Control group (n = 30) | All (n = 56) | Between group |
|---|---|---|---|---|
| Age (years): mean (SD) | 84.12 (5.52) | 83.73 (6.44) | 83.91 (5.98) | Z = −0.13, p = 0.895 |
| Female:male ratio | 3.33: 1 (20, 6) | 4.00: 1 (24, 6) | 3.67: 1 (44, 12) | χ2 = 0.08, p = 0.780 |
| CDR score: mean (SD) | 1.17 (.49) | 1.37 (.63) | 1.28 (.57) | Z = 1.01, p = 0.315 |
| Medication: nonmedication ratio∗ | 0.30: 1 (6, 20) | 0.30: 1 (7, 23) | 0.30: 1 (13, 43) | χ2 = 0.00, p = 0.982 |
∗
Cholinesterase inhibitor.